Slow-freezing versus vitrification for human ovarian tissue cryopreservation

Klocke S, Buendgen N, Koester F, Eichenlaub-Ritter U, Griesinger G (2015)
Archives of Gynecology and Obstetrics 291(2): 419-426.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Autor*in
Klocke, Silke; Buendgen, Nana; Koester, Frank; Eichenlaub-Ritter, UrsulaUniBi; Griesinger, Georg
Abstract / Bemerkung
Ovarian tissue can be cryopreserved prior to chemotherapy using either the slow-freezing or the vitrification method; however, the data on the equality of the procedures are still conflicting. In this study, a comparison of the cryo-damage of human ovarian tissue induced by either vitrification or slow-freezing was performed. Ovarian tissue from 23 pre-menopausal patients was cryopreserved with either slow-freezing or vitrification. After thawing/warming, the tissue was histologically and immunohistochemically analyzed and cultured in vitro. During tissue culture the estradiol release was assessed. No significant difference was found in the proportion of high-quality follicles after thawing/warming in the slow-freezing and vitrification group, respectively (72.7 versus 66.7 %, p = 0.733). Estradiol secretion by the ovarian tissue was similar between groups during 18 days in vitro culture (area-under-the-curve 5,411 versus 13,102, p = 0.11). Addition of Sphingosine-1-Phosphate or Activin A to the culture medium did not alter estradiol release in both groups. The proportion of Activated Caspase-3 or 'Proliferating-Cell-Nuclear-Antigen' positive follicles at the end of the culture period was similar between slow-freezing and vitrification. Slow-freezing and vitrification result in similar morphological integrity after cryopreservation, a similar estradiol release in culture, and similar rates of follicular proliferation and apoptosis after culture.
Stichworte
Vitrification; Slow-freezing; Cryopreservation; Human; Ovarian tissue
Erscheinungsjahr
2015
Zeitschriftentitel
Archives of Gynecology and Obstetrics
Band
291
Ausgabe
2
Seite(n)
419-426
ISSN
0932-0067
Page URI
https://pub.uni-bielefeld.de/record/2720040

Zitieren

Klocke S, Buendgen N, Koester F, Eichenlaub-Ritter U, Griesinger G. Slow-freezing versus vitrification for human ovarian tissue cryopreservation. Archives of Gynecology and Obstetrics. 2015;291(2):419-426.
Klocke, S., Buendgen, N., Koester, F., Eichenlaub-Ritter, U., & Griesinger, G. (2015). Slow-freezing versus vitrification for human ovarian tissue cryopreservation. Archives of Gynecology and Obstetrics, 291(2), 419-426. doi:10.1007/s00404-014-3390-6
Klocke, S., Buendgen, N., Koester, F., Eichenlaub-Ritter, U., and Griesinger, G. (2015). Slow-freezing versus vitrification for human ovarian tissue cryopreservation. Archives of Gynecology and Obstetrics 291, 419-426.
Klocke, S., et al., 2015. Slow-freezing versus vitrification for human ovarian tissue cryopreservation. Archives of Gynecology and Obstetrics, 291(2), p 419-426.
S. Klocke, et al., “Slow-freezing versus vitrification for human ovarian tissue cryopreservation”, Archives of Gynecology and Obstetrics, vol. 291, 2015, pp. 419-426.
Klocke, S., Buendgen, N., Koester, F., Eichenlaub-Ritter, U., Griesinger, G.: Slow-freezing versus vitrification for human ovarian tissue cryopreservation. Archives of Gynecology and Obstetrics. 291, 419-426 (2015).
Klocke, Silke, Buendgen, Nana, Koester, Frank, Eichenlaub-Ritter, Ursula, and Griesinger, Georg. “Slow-freezing versus vitrification for human ovarian tissue cryopreservation”. Archives of Gynecology and Obstetrics 291.2 (2015): 419-426.

21 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

In vitro Activation Prior to Transplantation of Human Ovarian Tissue: Is It Truly Effective?
Dolmans MM, Cordier F, Amorim CA, Donnez J, Vander Linden C., Front Endocrinol (Lausanne) 10(), 2019
PMID: 31428051
The evaluation of xenotransplantation of feline ovarian tissue vitrified by needle immersed vitrification technique into male immunodeficient mice.
Demirel MA, Acar DB, Ekim B, Çelikkan FT, Alkan KK, Salar S, Erdemli EA, Özkavukçu S, Yar SS, Kanca H, Baştan A., Cell Tissue Bank 19(1), 2018
PMID: 29039070
What is the net effect of introducing vitrification for cryopreservation of surplus 2PN oocytes in an IVF program?
Golakov M, Depenbusch M, Schultze-Mosgau A, Schoepper B, Hajek J, Neumann K, Griesinger G., Arch Gynecol Obstet 297(2), 2018
PMID: 29230537
Successful in Vitro Fertilization and Embryo Transfer after Transplantation of Cryopreserved Ovarian Tissue: Report of the First Korean Case.
Lee JR, Lee D, Park S, Paik EC, Kim SK, Jee BC, Suh CS, Kim SH., J Korean Med Sci 33(21), 2018
PMID: 29780295
Ovarian tissue cryopreservation and transplantation in patients with cancer.
Kim S, Lee Y, Lee S, Kim T., Obstet Gynecol Sci 61(4), 2018
PMID: 30018897
Oncofertility for women with gynecologic malignancies.
Chan JL, Wang ET., Gynecol Oncol 144(3), 2017
PMID: 28012689
Cryopreservation of human ovarian tissue using the silver closed vitrification system.
Xiao Z, Zhang Y, Fan W., J Assist Reprod Genet 34(11), 2017
PMID: 28756496
In Vitro Activation: A Possible New Frontier for Treatment of Primary Ovarian Insufficiency.
Cordeiro CN, Christianson MS, Selter JH, Segars JH., Reprod Sci 23(4), 2016
PMID: 26787101
Human single follicle growth in vitro from cryopreserved ovarian tissue after slow freezing or vitrification.
Wang TR, Yan J, Lu CL, Xia X, Yin TL, Zhi X, Zhu XH, Ding T, Hu WH, Guo HY, Li R, Yan LY, Qiao J., Hum Reprod 31(4), 2016
PMID: 26851603
Supplementation of transport and freezing media with anti-apoptotic drugs improves ovarian cortex survival.
Henry L, Fransolet M, Labied S, Blacher S, Masereel MC, Foidart JM, Noel A, Nisolle M, Munaut C., J Ovarian Res 9(), 2016
PMID: 26868273
Successful slush nitrogen vitrification of human ovarian tissue.
Talevi R, Barbato V, Fiorentino I, Braun S, De Stefano C, Ferraro R, Sudhakaran S, Gualtieri R., Fertil Steril 105(6), 2016
PMID: 26902858
Fertility preservation through gonadal cryopreservation.
Devi L, Goel S., Reprod Med Biol 15(4), 2016
PMID: 29259441
Modulation of aquaporins 3 and 9 after exposure of ovine ovarian tissue to cryoprotectants followed by in vitro culture.
Sales AD, Duarte AB, Santos RR, Alves KA, Lima LF, Rodrigues GQ, Brito IR, Lobo CH, Bruno JB, Locatelli Y, Figueiredo JR, Rodrigues AP., Cell Tissue Res 365(2), 2016
PMID: 26975215
Morphological, ultrastructural and functional imaging of frozen/thawed and vitrified/warmed human ovarian tissue retrieved from oncological patients.
Fabbri R, Vicenti R, Macciocca M, Martino NA, Dell'Aquila ME, Pasquinelli G, Morselli-Labate AM, Seracchioli R, Paradisi R., Hum Reprod 31(8), 2016
PMID: 27282911
Effect of Human Ovarian Tissue Vitrification/Warming on the Expression of Genes Related to Folliculogenesis.
Shams Mofarahe Z, Ghaffari Novin M, Jafarabadi M, Salehnia M, Noroozian M, Ghorbanmehr N., Iran Biomed J 19(4), 2015
PMID: 26175108
New advances in ovarian autotransplantation to restore fertility in cancer patients.
Salama M, Woodruff TK., Cancer Metastasis Rev 34(4), 2015
PMID: 26589603

47 References

Daten bereitgestellt von Europe PubMed Central.

Fertility management for women with cancer.
Agarwal SK, Chang RJ., Cancer Treat. Res. 138(), 2007
PMID: 18080654
Reproduction rates after cancer treatment: experience from the Norwegian radium hospital.
Cvancarova M, Samuelsen SO, Magelssen H, Fossa SD., J. Clin. Oncol. 27(3), 2008
PMID: 19075285
Preservation of fertility in patients with cancer.
Jeruss JS, Woodruff TK., N. Engl. J. Med. 360(9), 2009
PMID: 19246362
Rates of postcancer parenthood.
Schover LR., J. Clin. Oncol. 27(3), 2008
PMID: 19075256
Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue.
Andersen CY, Rosendahl M, Byskov AG, Loft A, Ottosen C, Dueholm M, Schmidt KL, Andersen AN, Ernst E., Hum. Reprod. 23(10), 2008
PMID: 18603535
Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation.
Dittrich R, Lotz L, Keck G, Hoffmann I, Mueller A, Beckmann MW, van der Ven H, Montag M., Fertil. Steril. 97(2), 2011
PMID: 22177311
Livebirth after orthotopic transplantation of cryopreserved ovarian tissue.
Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, Martinez-Madrid B, van Langendonckt A., Lancet 364(9443), 2004
PMID: 15488215
The first woman to give birth to two children following transplantation of frozen/thawed ovarian tissue.
Ernst E, Bergholdt S, Jorgensen JS, Andersen CY., Hum. Reprod. 25(5), 2010
PMID: 20172869
Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy.
Meirow D, Levron J, Eldar-Geva T, Hardan I, Fridman E, Zalel Y, Schiff E, Dor J., N. Engl. J. Med. 353(3), 2005
PMID: 15983020
Comparison of survival and embryonic development in human oocytes cryopreserved by slow-freezing and vitrification.
Cao YX, Xing Q, Li L, Cong L, Zhang ZG, Wei ZL, Zhou P., Fertil. Steril. 92(4), 2008
PMID: 18930218
Human oocyte vitrification: in-vivo and in-vitro maturation outcomes.
Chang CC, Shapiro DB, Bernal DP, Wright G, Kort HI, Nagy ZP., Reprod. Biomed. Online 17(5), 2008
PMID: 18983753

ZP, Semin Reprod Med 27(6), 2010
Embryo development of fresh 'versus' vitrified metaphase II oocytes after ICSI: a prospective randomized sibling-oocyte study.
Rienzi L, Romano S, Albricci L, Maggiulli R, Capalbo A, Baroni E, Colamaria S, Sapienza F, Ubaldi F., Hum. Reprod. 25(1), 2009
PMID: 19861328
Vitrification as an alternative means of cryopreserving ovarian tissue.
Amorim CA, Curaba M, Van Langendonckt A, Dolmans MM, Donnez J., Reprod. Biomed. Online 23(2), 2011
PMID: 21676653
Oocyte cryostorage to preserve fertility in oncological patients.
Revelli A, Molinari E, Salvagno F, Delle Piane L, Dolfin E, Ochetti S., Obstet Gynecol Int 2012(), 2012
PMID: 22291711
Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation.
Smitz J, Dolmans MM, Donnez J, Fortune JE, Hovatta O, Jewgenow K, Picton HM, Plancha C, Shea LD, Stouffer RL, Telfer EE, Woodruff TK, Zelinski MB., Hum. Reprod. Update 16(4), 2010
PMID: 20124287
Human ovarian tissue vitrification versus conventional freezing: morphological, endocrinological, and molecular biological evaluation.
Isachenko V, Lapidus I, Isachenko E, Krivokharchenko A, Kreienberg R, Woriedh M, Bader M, Weiss JM., Reproduction 138(2), 2009
PMID: 19439559
Successful vitrification of bovine and human ovarian tissue.
Kagawa N, Silber S, Kuwayama M., Reprod. Biomed. Online 18(4), 2009
PMID: 19401001
Vitrification versus controlled-rate freezing in cryopreservation of human ovarian tissue.
Keros V, Xella S, Hultenby K, Pettersson K, Sheikhi M, Volpe A, Hreinsson J, Hovatta O., Hum. Reprod. 24(7), 2009
PMID: 19359339
Comparison of necrosis in human ovarian tissue after conventional slow freezing or vitrification and transplantation in ovariectomized SCID mice.
Rahimi G, Isachenko E, Isachenko V, Sauer H, Wartenberg M, Tawadros S, Hescheler J, Mallmann P, Nawroth F., Reprod. Biomed. Online 9(2), 2004
PMID: 15333249
Roles of activin and its signal transduction mechanisms in reproductive tissues.
Ethier JF, Findlay JK., Reproduction 121(5), 2001
PMID: 11427154
Recruitment and development of the follicle; the roles of the transforming growth factor-beta superfamily.
Findlay JK, Drummond AE, Dyson ML, Baillie AJ, Robertson DM, Ethier JF., Mol. Cell. Endocrinol. 191(1), 2002
PMID: 12044917
Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy.
Morita Y, Perez GI, Paris F, Miranda SR, Ehleiter D, Haimovitz-Friedman A, Fuks Z, Xie Z, Reed JC, Schuchman EH, Kolesnick RN, Tilly JL., Nat. Med. 6(10), 2000
PMID: 11017141

A, Fertil Steril 81(Suppl 1), 2004
Restoration of fertility to oophorectomized sheep by ovarian autografts stored at -196 degrees C.
Gosden RG, Baird DT, Wade JC, Webb R., Hum. Reprod. 9(4), 1994
PMID: 8046009
Restoration of ovarian function in orthotopically transplanted cryopreserved ovarian tissue: a pilot experience.
Donnez J, Squifflet J, Van Eyck AS, Demylle D, Jadoul P, Van Langendonckt A, Dolmans MM., Reprod. Biomed. Online 16(5), 2008
PMID: 18492374

A, Ann Biol Anim Biochem Biophys 19(), 1979

R, Rejuv Res 10(1), 2007
Sphingosine 1-phosphate signalling in mammalian cells.
Pyne S, Pyne NJ., Biochem. J. 349(Pt 2), 2000
PMID: 10880336
Sphingosine 1-phosphate as a therapeutic agent.
Spiegel S, Kolesnick R., Leukemia 16(9), 2002
PMID: 12200669
Intraovarian activins are required for female fertility.
Pangas SA, Jorgez CJ, Tran M, Agno J, Li X, Brown CW, Kumar TR, Matzuk MM., Mol. Endocrinol. 21(10), 2007
PMID: 17609433
The effects of FSH and activin A on follicle development in vitro.
Cossigny DA, Findlay JK, Drummond AE., Reproduction 143(2), 2011
PMID: 22106407
Activin A inhibits activation of human primordial follicles in vitro.
Ding CC, Thong KJ, Krishna A, Telfer EE., J. Assist. Reprod. Genet. 27(4), 2010
PMID: 20198416
Does sphingosine-1-phosphate have a protective effect on cyclophosphamide- and irradiation-induced ovarian damage in the rat model?
Kaya H, Desdicioglu R, Sezik M, Ulukaya E, Ozkaya O, Yilmaztepe A, Demirci M., Fertil. Steril. 89(3), 2007
PMID: 17517398
Ovarian transplantation for fertility preservation in a sheep model: can follicle loss be prevented by antiapoptotic sphingosine-1-phosphate administration?
Hancke K, Walker E, Strauch O, Gobel H, Hanjalic-Beck A, Denschlag D., Gynecol. Endocrinol. 25(12), 2009
PMID: 19906004

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 25115279
PubMed | Europe PMC

Suchen in

Google Scholar